Baalbergen Astrid, Veenstra Yerney, Stalpers Lukas L, Ansink Anca C
Department of Obstetrics and Gynaecology, Reinier de Graaf Groep, Postbus 5011, Delft, Netherlands, 2600 GA.
Cochrane Database Syst Rev. 2010 Jan 20(1):CD006248. doi: 10.1002/14651858.CD006248.pub2.
For early squamous cell carcinoma of the uterine cervix, the outcome is similar after either primary surgery or primary radiotherapy. There are reports that this is not the case for early adenocarcinoma (AC) of the uterine cervix: some studies have reported that the outcome is better after primary surgery. There are no systematic reviews about surgery versus chemoradiation in the treatment of cervical cancer.
The objectives of this review were to compare the effectiveness and safety of primary surgery for early stage AC of the uterine cervix with primary radiotherapy or chemoradiation.
We searched Cochrane Central Register of Controlled Trials (CENTRAL) Issue 3, 2009, MEDLINE (1950 to July week 5, 2009), EMBASE (1980 to week 32, 2009) and we also searched the related articles feature of PubMed and the Web of Science. We also checked the reference lists of articles.
Studies of treatment of patients with early AC of the uterine cervix were included. Treatment included surgery, surgery followed by radiotherapy, radiotherapy and chemoradiation.
Forty-three studies were selected by the search strategy and thirty studies were excluded. Twelve studies were considered for inclusion. Except for one randomised controlled trial (RCT), all other studies were retrospective cohort studies with variable methodological quality and had limitations of a retrospective study. Comparing the results from these retrospective studies was not possible due to diverging treatment strategies.
Analysis of a subgroup of one RCT showed that surgery for early cervical AC was better than RT. However, the majority of operated patients required adjuvant radiotherapy, which is associated with greater morbidity. Furthermore, the radiotherapy in this study was not optimal, and surgery was not compared to chemoradiation, which is currently recommended in most centres. Finally, modern imaging techniques, i.e. MR-imaging and PET-CT-scanning, allow better selection of patients and node negative patients can now be more easily identified for surgery, there by reducing the risk of 'double trouble' caused by surgery and adjuvant radiotherapy.
AUTHORS' CONCLUSIONS: We recommend surgery for early stage AC of the uterine cervix in carefully staged patients. Primary chemoradiation remains a second best alternative for patients unfit for surgery; chemoradiation is probably first choice in patients with (MRI or PET-CT-suspected) positive lymph nodes.
对于早期子宫颈鳞状细胞癌,原发手术或原发放疗后的结局相似。有报告称子宫颈早期腺癌(AC)并非如此:一些研究报告称原发手术后结局更好。关于子宫颈癌治疗中手术与放化疗的比较尚无系统评价。
本评价的目的是比较子宫颈早期腺癌原发手术与原发放疗或放化疗的有效性和安全性。
我们检索了《Cochrane系统评价数据库》2009年第3期、《医学索引》(1950年至2009年7月第5周)、《荷兰医学文摘数据库》(1980年至2009年第32周),我们还检索了PubMed的相关文章特色和科学网。我们也检查了文章的参考文献列表。
纳入子宫颈早期腺癌患者治疗的研究。治疗包括手术、手术后放疗、放疗和放化疗。
通过检索策略选择了43项研究,排除了30项研究。12项研究被考虑纳入。除一项随机对照试验(RCT)外,所有其他研究均为回顾性队列研究,方法学质量各异,且有回顾性研究的局限性。由于治疗策略不同,无法比较这些回顾性研究的结果。
对一项RCT的一个亚组分析表明子宫颈早期AC手术优于放疗。然而,大多数接受手术的患者需要辅助放疗,这与更高的发病率相关。此外,本研究中的放疗并非最佳,且未将手术与目前大多数中心推荐的放化疗进行比较。最后,现代成像技术,即磁共振成像和正电子发射断层显像-计算机断层扫描,能更好地选择患者,现在可以更容易地识别出淋巴结阴性患者进行手术,从而降低手术和辅助放疗引起的“双重麻烦”风险。
我们建议对分期明确的子宫颈早期腺癌患者进行手术。原发放化疗仍是不适合手术患者的次优选择;对于(磁共振成像或正电子发射断层显像-计算机断层扫描怀疑)淋巴结阳性的患者,放化疗可能是首选。